Omics-based Clinical Trials Market Is Set For Lucrative Growth To 2030
Omics-based Clinical Trials Market Summary The global omics-based clinical trials market was valued at USD 32.64 billion in 2024 and is anticipated to reach USD 51.77 billion by 2030, expanding at a compound annual growth rate (CAGR) of 8.02% from 2025 to 2030. The market growth is primarily driven by rapid advancements in omics technologies, the rising demand for personalized medicine, significant investments by pharmaceutical companies to improve drug development efficiency, and the support of favorable regulatory frameworks. These factors are collectively propelling the adoption of omics-based strategies in clinical trials to enhance the precision and efficacy of treatments. Technological innovations such as next-generation sequencing (NGS) and high-throughput screening techniques have drastically reduced the cost and duration of genomic data analysis. These cutting-edge tools allow researchers to perform large-scale studies with greater accuracy and speed, facilit...